The control effects of six kinds of reagents against rice sheath blight were compared in the test. The results showed that 24% thifluzamide SC 300 mL/hm2 and 20% Jinggangmycin ~ prochloraz WP 750 g/hm2 had good contro...The control effects of six kinds of reagents against rice sheath blight were compared in the test. The results showed that 24% thifluzamide SC 300 mL/hm2 and 20% Jinggangmycin ~ prochloraz WP 750 g/hm2 had good control effect against rice sheath blight, and their control effects after spraying for 7 and 14 d were 72.16%, 77.91% and 66.52%, 71.08%, respectively. The control effects of both reagents were significantly better than other test reagents and control re- agent Jinggangmycin, and they had no adverse effect on growth and development of rice. Considering from the aspects of control effect and economy, 20% Jinggang- mycin ~ prochloraz WP was suggested to be used to control rice sheath blight, its recommended dosage was 600 -750 g/hm2, and the reagent volume was 750kg with coarse spraying.展开更多
Objective:To observe clinical efficacy of Lanzhou Formula(兰州方)with Bingpeng Powder(冰硼散)mouthwash in preventing and treating radiation-induced oral mucositis.Methods:A total of 200 patients with malignant tumors ...Objective:To observe clinical efficacy of Lanzhou Formula(兰州方)with Bingpeng Powder(冰硼散)mouthwash in preventing and treating radiation-induced oral mucositis.Methods:A total of 200 patients with malignant tumors in the head and neck who received radiotherapy in our hospital from April 2018 to April 2020 were selected as research objects,and they were randomly divided into the study group and control group.The control group was given radiotherapy combined with mouthwash,which consisted of 500 mL of normal saline,125 mg of vitamin B12,400000 U of gentamicin and 1 g of lidocaine.The study group was given radiotherapy combined with Lanzhou Formula with Bingpeng Powder mouthwash.Incidences of radiation-induced oral mucositis,chewing and swallowing functions,and Karnofsky(KPS)scores were compared between the 2 groups.Results:At the end of the radiotherapy,there was no Grade 4 radiation-induced oral mucositis in the 2 groups.Compared with the control group,the radiation-induced oral mucositis in the study group basically belonged to Grade 1 and Grade 2,with a lower incidence of Grade 3(P<0.05).At the end of the radiotherapy,the chewing and swallowing functions in the 2 groups were decreased,but patients with 2-point chewing and swallowing functions in the study group were more than those in the control group,and patients with the 3-point were less than those in the control group(P<0.05).At the end of the radiotherapy,the KPS scores were decreased,but those in the study group were higher than those in the control group(P<0.05).Conclusion:During radiotherapy for patients with malignant tumors in the head and neck,Lanzhou Formula with Bingpeng Powder mouthwash can decrease the severity of radiation-induced oral mucositis,protect chewing and swallowing functions of patients to a certain extent,and improve the general condition of patients.It is worthy of clinical application and promotion.展开更多
Background A hepatic adverse event(HAE)is defined as a liver injury that occurs following immune checkpoint inhibitor(ICI)administration in oncology Patients.Immune-mediated hepatotoxicity(IMH)is a type of HAE directl...Background A hepatic adverse event(HAE)is defined as a liver injury that occurs following immune checkpoint inhibitor(ICI)administration in oncology Patients.Immune-mediated hepatotoxicity(IMH)is a type of HAE directly caused by ICI and is associated with immune system hyperactivation.HAE incidence varies across different clinical studies.This study aimed to explore the risk factors of HAE and establish a personalized IMH treatment strategy.Methods Randomized controlled trials(RCTs)on ICIs and case reports related to IMH were collected and summarized separately.Meta-analysis was performed using Review Manager(version 5.0),whereas correlation analysis and linear regression were performed using SPSS(version 24.0)to evaluate any correlations between the two variables.Results Overall,36 RCTs containing 18,515 patients and 39 case reports met our inclusion criteria.The ICI administration increased the HAE risk(risk ratio[RR]=1.40)as well as severe HAE(RR=2.55).The overall HAE incidence and severe incidence were about 15.3%and 4.3%,respectively.Cytotoxic T-lymphocyte-associated protein 4(CTLA-4)inhibitors have a higher incidence of HAE than programmed cell death protein 1(PD-1)and programmed death-ligand 1(PD-L1)inhibitors.Finally,we found a positive correlation between the onset time of IMH and the recovery time of liver injury.Conclusions ICI administration increased the incidence risk of HAE,especially in patients treated with CTLA-4 inhibitors.Regarding IMH treatment,the glucocorticoid dosage must be individually reduced according to the severity and onset time of HAE.展开更多
Immune checkpoint inhibitors(ICIs)are a class of antitumor medications that target immune checkpoints,which induce the activation of lymphocytes.These treatments effectively prolong the survival of patients with advan...Immune checkpoint inhibitors(ICIs)are a class of antitumor medications that target immune checkpoints,which induce the activation of lymphocytes.These treatments effectively prolong the survival of patients with advanced tumors,especially lung cancer.However,in addition to tumor killing effects,ICIs may also cause an imbalance between immune tolerance and immunity.Over-activated lymphocytes may cause various types of damage to multiple organs throughout the body,called immune-related adverse events.In this review,we summarize the pathogenesis,pathological characteristics,biomarkers,and therapeutic agents for immune-related adverse events.展开更多
Chronic obstructive pulmonary disease(COPD),characterized by persistent and not fully reversible airflow restrictions,is currently one of the most widespread chronic lung diseases in the world.The most common symptoms...Chronic obstructive pulmonary disease(COPD),characterized by persistent and not fully reversible airflow restrictions,is currently one of the most widespread chronic lung diseases in the world.The most common symptoms of COPD are cough,expectoration,and exertional dyspnea.Although various strategies have been developed during the last few decades,current medical treatment for COPD only focuses on the relief of symptoms,and the reversal of lung function deterioration and improvement in patient^quality of life are very limited.Consequently,development of novel effective therapeutic strategies for COPD is urgently needed.Stem cells were known to differentiate into a variety of cell types and used to regenerate lung parenchyma and airway structures.Stem cell therapy is a promising therapeutic strategy that has the potential to restore the lung function and improve the quality of life in patients with COPD.This review summarizes the current state of knowledge regarding the clinical research on the treatment of COPD with mesenchymal stem cells(MSCs)and aims to update the understanding of the role of MSCs in COPD treatment,which may be helpful for developing effective therapeutic strategies in clinical settings.展开更多
Pyrotinib is a novel human epidermal growth factor receptor 2(HER2)tyrosine kinase inhibitor(TKI).Previous studies of pyrotinib showed that it is mainly excreted through the gastrointestinal tract rather than the kidn...Pyrotinib is a novel human epidermal growth factor receptor 2(HER2)tyrosine kinase inhibitor(TKI).Previous studies of pyrotinib showed that it is mainly excreted through the gastrointestinal tract rather than the kidneys,with little effect on renal function.Here,we report a patient with HER2-mutated nonsmall cell lung cancer who developed acute kidney injury(AKI)after receiving pyrotinib treatment.This case alerts clinicians to the adverse renal effects of HER2 TKIs,especially in patients with chronic kidney disease.However,tumor treatment should remain a priority in clinical practice.In this case,AKI induced by pyrotinib was reversible.Therefore,there is no need to restrict the use of HER2 TKIs due to concerns about possible nephrotoxicity.展开更多
基金Supported by National Torch Plan Project(2010GH020365)Jurong Authorized Invention Patent Achievement Transformation Project of Jiangsu Province (ZL201003)
文摘The control effects of six kinds of reagents against rice sheath blight were compared in the test. The results showed that 24% thifluzamide SC 300 mL/hm2 and 20% Jinggangmycin ~ prochloraz WP 750 g/hm2 had good control effect against rice sheath blight, and their control effects after spraying for 7 and 14 d were 72.16%, 77.91% and 66.52%, 71.08%, respectively. The control effects of both reagents were significantly better than other test reagents and control re- agent Jinggangmycin, and they had no adverse effect on growth and development of rice. Considering from the aspects of control effect and economy, 20% Jinggang- mycin ~ prochloraz WP was suggested to be used to control rice sheath blight, its recommended dosage was 600 -750 g/hm2, and the reagent volume was 750kg with coarse spraying.
基金Scientific Research Projects of Gansu Provincial Administration of Traditional Chinese Medicine(GZK-2017-40)。
文摘Objective:To observe clinical efficacy of Lanzhou Formula(兰州方)with Bingpeng Powder(冰硼散)mouthwash in preventing and treating radiation-induced oral mucositis.Methods:A total of 200 patients with malignant tumors in the head and neck who received radiotherapy in our hospital from April 2018 to April 2020 were selected as research objects,and they were randomly divided into the study group and control group.The control group was given radiotherapy combined with mouthwash,which consisted of 500 mL of normal saline,125 mg of vitamin B12,400000 U of gentamicin and 1 g of lidocaine.The study group was given radiotherapy combined with Lanzhou Formula with Bingpeng Powder mouthwash.Incidences of radiation-induced oral mucositis,chewing and swallowing functions,and Karnofsky(KPS)scores were compared between the 2 groups.Results:At the end of the radiotherapy,there was no Grade 4 radiation-induced oral mucositis in the 2 groups.Compared with the control group,the radiation-induced oral mucositis in the study group basically belonged to Grade 1 and Grade 2,with a lower incidence of Grade 3(P<0.05).At the end of the radiotherapy,the chewing and swallowing functions in the 2 groups were decreased,but patients with 2-point chewing and swallowing functions in the study group were more than those in the control group,and patients with the 3-point were less than those in the control group(P<0.05).At the end of the radiotherapy,the KPS scores were decreased,but those in the study group were higher than those in the control group(P<0.05).Conclusion:During radiotherapy for patients with malignant tumors in the head and neck,Lanzhou Formula with Bingpeng Powder mouthwash can decrease the severity of radiation-induced oral mucositis,protect chewing and swallowing functions of patients to a certain extent,and improve the general condition of patients.It is worthy of clinical application and promotion.
文摘Background A hepatic adverse event(HAE)is defined as a liver injury that occurs following immune checkpoint inhibitor(ICI)administration in oncology Patients.Immune-mediated hepatotoxicity(IMH)is a type of HAE directly caused by ICI and is associated with immune system hyperactivation.HAE incidence varies across different clinical studies.This study aimed to explore the risk factors of HAE and establish a personalized IMH treatment strategy.Methods Randomized controlled trials(RCTs)on ICIs and case reports related to IMH were collected and summarized separately.Meta-analysis was performed using Review Manager(version 5.0),whereas correlation analysis and linear regression were performed using SPSS(version 24.0)to evaluate any correlations between the two variables.Results Overall,36 RCTs containing 18,515 patients and 39 case reports met our inclusion criteria.The ICI administration increased the HAE risk(risk ratio[RR]=1.40)as well as severe HAE(RR=2.55).The overall HAE incidence and severe incidence were about 15.3%and 4.3%,respectively.Cytotoxic T-lymphocyte-associated protein 4(CTLA-4)inhibitors have a higher incidence of HAE than programmed cell death protein 1(PD-1)and programmed death-ligand 1(PD-L1)inhibitors.Finally,we found a positive correlation between the onset time of IMH and the recovery time of liver injury.Conclusions ICI administration increased the incidence risk of HAE,especially in patients treated with CTLA-4 inhibitors.Regarding IMH treatment,the glucocorticoid dosage must be individually reduced according to the severity and onset time of HAE.
文摘Immune checkpoint inhibitors(ICIs)are a class of antitumor medications that target immune checkpoints,which induce the activation of lymphocytes.These treatments effectively prolong the survival of patients with advanced tumors,especially lung cancer.However,in addition to tumor killing effects,ICIs may also cause an imbalance between immune tolerance and immunity.Over-activated lymphocytes may cause various types of damage to multiple organs throughout the body,called immune-related adverse events.In this review,we summarize the pathogenesis,pathological characteristics,biomarkers,and therapeutic agents for immune-related adverse events.
基金supported by grants from the National Key Research and Development Program of China(No.2018YFC1313602)Major International(Regional)Joint Research Project(No.81820108001)+2 种基金National Natural Science Foundation of China(No.81670029)Jiangsu Key Principal Investigator of Medicine(No.ZDRCA2016018)Nanjing Key Project of Science and Technology(No.2019060002)(to L.Zhou).
文摘Chronic obstructive pulmonary disease(COPD),characterized by persistent and not fully reversible airflow restrictions,is currently one of the most widespread chronic lung diseases in the world.The most common symptoms of COPD are cough,expectoration,and exertional dyspnea.Although various strategies have been developed during the last few decades,current medical treatment for COPD only focuses on the relief of symptoms,and the reversal of lung function deterioration and improvement in patient^quality of life are very limited.Consequently,development of novel effective therapeutic strategies for COPD is urgently needed.Stem cells were known to differentiate into a variety of cell types and used to regenerate lung parenchyma and airway structures.Stem cell therapy is a promising therapeutic strategy that has the potential to restore the lung function and improve the quality of life in patients with COPD.This review summarizes the current state of knowledge regarding the clinical research on the treatment of COPD with mesenchymal stem cells(MSCs)and aims to update the understanding of the role of MSCs in COPD treatment,which may be helpful for developing effective therapeutic strategies in clinical settings.
文摘Pyrotinib is a novel human epidermal growth factor receptor 2(HER2)tyrosine kinase inhibitor(TKI).Previous studies of pyrotinib showed that it is mainly excreted through the gastrointestinal tract rather than the kidneys,with little effect on renal function.Here,we report a patient with HER2-mutated nonsmall cell lung cancer who developed acute kidney injury(AKI)after receiving pyrotinib treatment.This case alerts clinicians to the adverse renal effects of HER2 TKIs,especially in patients with chronic kidney disease.However,tumor treatment should remain a priority in clinical practice.In this case,AKI induced by pyrotinib was reversible.Therefore,there is no need to restrict the use of HER2 TKIs due to concerns about possible nephrotoxicity.
